Position in AZN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$233,914,282
-$134,860,295 QoQ
Shares Held
1,233,595
-34.0% QoQ
Ownership
0.080%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#94
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 56%
None 44%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VOYA INVESTMENT MANAGEMENT LLC holds $4,379,567,692 across 14 Drug Manufacturers - General names. AZN ranks #5 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,190,792 | $1,428,271,766 | |
| 2 | MRK |
Merck & Co., Inc.
|
6,484,756 | $833,291,145 | |
| 3 | JNJ |
Johnson & Johnson
|
3,255,567 | $826,816,350 | |
| 4 | ABBV |
AbbVie Inc.
|
2,374,888 | $597,616,815 | |
| 5 | AZN |
Astrazeneca PLC
This page
|
1,233,595 | $233,914,282 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,845,511 | $233,161,858 | |
| 7 | AMGN |
Amgen Inc
|
195,409 | $70,761,506 | |
| 8 | BIIB |
Biogen Inc.
|
246,782 | $53,319,718 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $233,914,282 | 1,233,595 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $368,774,577 | 1,869,864 | Shares | Defined | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||